Clinical trials are essential for generating reliable evidence, but many trials still face avoidable barriers: complex protocols, unnecessary data collection, slow approval processes, limited participants’ diversity, and delayed reporting of…
Continue readingParticipant recruitment remains a major challenge in clinical research. Delays in enrolment can extend timelines, increase costs, and affect study delivery. As a result, financial incentives are often discussed as…
Continue readingThis is our discussion with Lydia Ainsworth which was recorded for the Solutions OP Clinical Trials podcast. You can listen to the original recording here. Please note that the discussion below is adapted and…
Continue readingThis is our discussion with Tetsu Yung which was recorded for the Solutions OP Clinical Trials podcast. You can listen to the original recording here. Please note that the interview below is adapted and…
Continue readingThis is our discussion with Lydia Ainsworth which was recorded for the Solutions OP Clinical Trials podcast. You can listen to the original recording here. Please note that the interview below is adapted and…
Continue readingThis is our discussion with Dr Daphne Hazell which was recorded for the Solutions OP Clinical Trials podcast. You can listen to the original recording here. Please note that the interview below is adapted…
Continue readingThis is our discussion with Liz Hawes which was recorded for the Solutions OP Clinical Trials podcast. You can listen to the original recording here. Please note that the interview below is adapted and…
Continue readingThe Health Sciences Authority (HSA) is Singapore’s national regulatory agency responsible for ensuring the safety, quality, and efficacy of health products, including the oversight of clinical trials. HSA reviews and…
Continue readingThis is our discussion with Keith Berelowitz which was recorded for the Solutions OP Clinical Trials podcast. You can listen to the original recording here. Please note that the interview below is adapted and…
Continue readingTo conduct a clinical trial in China, applicants must obtain approval from both an Ethics Committee (EC) and the National Medical Products Administration (NMPA). The Center for Drug Evaluation (CDE)…
Continue reading